Sp257
OPTIMIZING ADHERENCE TO COLON CANCER SCREENING: WHAT WORKS
Date
May 6, 2023
Explore related products in the following collection:
Society: AGA
Review updates and current considerations in colon cancer screening and surveillance related topics.
Review updates and current considerations in colon cancer screening and surveillance related topics.
Presenter
Tracks
Related Products
PANEL DISCUSSION
Review updates and current considerations in colon cancer screening and surveillance related topics…
STATE OF THE ART: COMPLEXITIES OF SCREENING (AGE, FIT, NORDICC) - WHAT DO I DO IN 2023?
BACKGROUND: Health status and expected mortality are important considerations in assessing the benefits of colorectal cancer (CRC) screening, particularly for older adults given that CRC screening is recommended for adults with life expectancy ≥10 years…
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
